These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38006690)

  • 1. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
    Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
    Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
    Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.
    Lilja-Fischer JK; Kristensen MH; Lassen P; Steiniche T; Tramm T; Stougaard M; Maare C; Johansen J; Primdahl H; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
    Acta Oncol; 2023 Nov; 62(11):1384-1388. PubMed ID: 37837201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus and p16
    Lu Y; Clifford GM; Fairley CK; Grulich AE; Garland SM; Xiao F; Wang Y; Zou H
    Int J Cancer; 2024 Mar; 154(5):830-841. PubMed ID: 37861207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
    Fonsêca TC; Jural LA; Marañón-Vásquez GA; Magno MB; Roza ALOC; Ferreira DMTP; Maia LC; Romañach MJ; Agostini M; Abrahão AC
    Clin Oral Investig; 2023 Dec; 28(1):62. PubMed ID: 38158517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
    Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
    Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 18. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
    Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
    Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.